Targeting Senescence to Reduce Osteoarthritis Pain and cartilagE Breakdown (ROPE)

NCT04770064 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding was not awarded

Conditions

Osteoarthritis, Knee

Interventions

DRUG: High-dose/short-duration Fisetin
DRUG: Low-dose/sustained-duration Fisetin
OTHER: Oral placebo capsule

Sponsor

Austin V Stone

Collaborators

[object Object]